Biomedicine News and Research

RSS

Scientists report new family of selective molecules to combat causal agent of malaria

Malaria is one of the most serious health problems worldwide, registering 200 million clinical cases and more than 600,000 attributable deaths per year, according to information from the World Health Organization in 2013. Given the emerging resistance to the standard treatment most widely used throughout the world, which is based on artemisinin and its analogs, there is a need for new antimalarial compounds.

11 Dec 2014

Predictive model provides information for treating 20% of human diseases

The analysis of drugs, natural products, and chemical substances found in the environment allows the identification of the chemical fragments responsible for a therapeutic or deleterious effect on human health.

1 Dec 2014

New microbial analysis has implications for protecting environment, energy recovery and human health

An international team of scientists from the Translational Genomics Research Institute and The Luxembourg Centre for Systems Biomedicine have completed a first-of-its-kind microbial analysis of a biological wastewater treatment plant that has broad implications for protecting the environment, energy recovery and human health.

27 Nov 2014

Researchers synthetize molecules to block virus that causes influenza A

The influenza A virus is a contagious and severe respiratory infection that affects animals but also humans. Researchers from the University of Barcelona have synthetized some molecules which are able to block the virus that causes influenza A and some of the mutations that make it resistant to common drugs.

7 Nov 2014

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

The Douglas Mental Health University Institute is proud to announce that its researcher and neurobiologist, Michael Meaney, C.M., Ph.D., C.Q., FRSC, is the 2014 laureate of the prestigious prix Wilder-Penfield.

4 Nov 2014

New NIH award aims to help increase diversity in biomedicine

The University of Alaska Fairbanks received a $23.8 million, five-year award from the National Institutes of Health to launch a new undergraduate program that will engage students from diverse backgrounds, especially those from rural Alaska, in biomedical research as a way to foster their interest and success in biomedical and health careers.

25 Oct 2014

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Across the country, billions of dollars and millions of hours are spent on studying the inner workings of the brain as scientists search for ways to treat debilitating diseases and injuries such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury. Now, with the tremendous growth in basic knowledge driven by these efforts, researchers see a need to integrate their work across the broad scientific disciplines represented in modern neuroscience.

16 Oct 2014

LCSB scientists characterize new tumour suppressor gene

Scientists at the Luxembourg Centre for Systems Biomedicine of the University of Luxembourg have published their findings that mutations in a gene known as "ARMC5" promote the growth of benign tumours in the adrenal glands and on the meninges: ARMC5 appears to belong to the group of so-called tumour suppressor genes.

14 Oct 2014

University of Pittsburgh awarded NIH grant to lead Big Data to Knowledge Center of Excellence

The National Institutes of Health has awarded the University of Pittsburgh an $11 million, four-year grant to lead a Big Data to Knowledge Center of Excellence, an initiative that will help scientists capitalize more fully on large amounts of available data and to make data science a more prominent component of biomedical research.

10 Oct 2014

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer. With two publications appearing in PLoS One and EMBO Reports, the IRB team also unveil the function of a key gene in the development of the disease.

9 Oct 2014

Researchers discover novel mechanisms of cell migration

During cancer metastasis, immune response or the development of organisms, cells are moving in a controlled manner through the body. Researchers from the Department of Biomedicine at the University of Basel discovered novel mechanisms of cell migration by observing cells moving on lines of connective tissue.

7 Oct 2014

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

A new study published in the prestigious publication The EMBO Journal shows that the mitochondrial protein Mfn2 may be a future therapeutic target for neuronal death reduction in the late phases of an ischemic stroke.

24 Sep 2014

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.

3 Sep 2014

Nasal septum cells can repair human articular cartilage defects

Human articular cartilage defects can be treated with nasal septum cells. Researchers at the University and the University Hospital of Basel report that cells taken from the nasal septum are able to adapt to the environment of the knee joint and can thus repair articular cartilage defects.

30 Aug 2014

Researchers restore missing repair protein in skeletal muscle of patients with muscular dystrophy

Advances in the treatment of muscular dystrophy: For the first time, a research team has succeeded in restoring a missing repair protein in skeletal muscle of patients with muscular dystrophy.

21 Aug 2014

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Scientists from the Biogerontology Research Foundation (BGRF), a UK-based charity founded to support ageing research and address the challenges of a rapidly ageing population, propose a new concept for signalome-wide analysis of changes in intracellular pathways, called OncoFinder, which allows for accurate and robust cross-platform analysis of gene expression data.

19 Aug 2014

Biomedicine News and Research

Scientists report new family of selective molecules to combat causal agent of malaria

Predictive model provides information for treating 20% of human diseases

New microbial analysis has implications for protecting environment, energy recovery and human health

Researchers synthetize molecules to block virus that causes influenza A

Douglas Mental Health University Institute researcher wins 2014 Wilder-Penfield prize

New NIH award aims to help increase diversity in biomedicine

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

LCSB scientists characterize new tumour suppressor gene

University of Pittsburgh awarded NIH grant to lead Big Data to Knowledge Center of Excellence

Researchers generate fruit fly model, unveil key genetic factors behind human colon cancer

Researchers discover novel mechanisms of cell migration

Mfn2 protein: A future therapeutic target for neuronal death reduction in ischemic stroke

Using iPS technology researchers develop new therapies for Parkinson's disease and ALS

Nasal septum cells can repair human articular cartilage defects

Researchers restore missing repair protein in skeletal muscle of patients with muscular dystrophy

BGRF scientists propose Oncofinder method for accurate analysis of gene expression data

Innate lymphoid cells induce specific T and B cell responses during inflammation

NIH challenges innovators to compete for prizes by developing new ways to track a single cell

Babies suffering from life-threatening bacterial infections could benefit from improved treatment

New approach to predict myeloma patients using calcium isotope analysis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News